Soluble Programmed Death-Ligand 1 (sPD-L1) as a Novel Biomarker for the Combination of Anti-PD-L1 Antibody and Radiotherapy for Glioma Patients

作者：X Ding, Zihan Zhou, Zhongqi Ge, Yujie Guo, Yanlai Chen, Shulun Nie, Jinming Yu, Man Hu · 发表于：International Journal of Radiation Oncology*Biology*Physics · 年份：2021 · DOI：10.1016/j.ijrobp.2021.07.1576 · 研究领域：Cancer Immunotherapy and Biomarkers、Glioma Diagnosis and Treatment、Nanoplatforms for cancer theranostics